(Circulation. 1997;95:1455-1463.)
© 1997 American Heart Association, Inc.
Articles |
Regulation of Local Angiotensin II Formation in the Human Heart in the Presence of Interstitial Fluid
Inhibition of Chymase by Protease Inhibitors of Interstitial Fluid and of Angiotensin-Converting Enzyme by Ang-(1-9) Formed by Heart Carboxypeptidase A–Like Activity
From the Wihuri Research Institute, Helsinki, Finland.
Correspondence to Dr Petri T. Kovanen, Wihuri Research Institute, Kalliolinnantie 4, FIN-00140 Helsinki, Finland.
Background Data from in vitro studies suggest that both chymase and ACE contribute to the local generation of angiotensin (Ang) II in the heart. The enzyme kinetics under in vivo conditions are unclear. We thus studied the generation of Ang II by cardiac tissue in the presence of interstitial fluid (IF) that contains a variety of naturally occurring protease inhibitors.
Methods and Results Ang I was incubated with heart
homogenate in the presence of IF. IF obtained from human skin contained
substantial amounts of protease inhibitors and ACE activity, the
concentration of 
1-antitrypsin being 35% and the
activity of ACE 24% of the corresponding serum values. When heart
homogenate was incubated with Ang I, three enzymes were responsible for
its metabolism: heart chymase and heart ACE converted Ang I to Ang II,
and heart carboxypeptidase A (CPA)–like activity degraded Ang I to
Ang-(1-9). Incubation of heart homogenate in the presence of IF led to
practically full inhibition of heart chymase–mediated Ang II formation
by the natural protease inhibitors present in IF. In contrast, heart
CPA–like activity was not blocked, as reflected by the continued
generation of Ang-(1-9). In addition, both heart ACE– and IF
ACE–mediated Ang II formation were strongly inhibited. This inhibition
was shown to be due to the Ang-(1-9) formed.
Conclusions The present experimental study defines two novel inhibitory mechanisms of Ang II formation in the human heart interstitium. Heart chymase–mediated Ang II formation is strongly inhibited by the natural protease inhibitors present in the IF. Similarly, both heart ACE– and IF ACE–mediated Ang II formation appear to be inhibited by the endogenous inhibitor Ang-(1-9) formed by heart CPA–like activity. These inhibitory mechanisms provide additional information about how the Ang II concentration in the heart interstitium may be controlled.
Key Words: angiotensin • heart failure • myocardium • remodeling
This article has been cited by other articles:
 |
|
 |
|
  V. Seyrantepe, A. Hinek, J. Peng, M. Fedjaev, S. Ernest, Y. Kadota, M. Canuel, K. Itoh, C. R. Morales, J. Lavoie, et al. Enzymatic Activity of Lysosomal Carboxypeptidase (Cathepsin) A Is Required for Proper Elastic Fiber Formation and Inactivation of Endothelin-1 Circulation, April 15, 2008; 117(15): 1973 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. van der Harst, M. Volbeda, A. A. Voors, H. Buikema, S. Wassmann, M. Bohm, G. Nickenig, and W. H. van Gilst Vascular Response to Angiotensin II Predicts Long-Term Prognosis in Patients Undergoing Coronary Artery Bypass Grafting Hypertension, December 1, 2004; 44(6): 930 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Campbell, T. Alexiou, H. D. Xiao, S. Fuchs, M. J. McKinley, P. Corvol, and K. E. Bernstein Effect of Reduced Angiotensin-Converting Enzyme Gene Expression and Angiotensin-Converting Enzyme Inhibition on Angiotensin and Bradykinin Peptide Levels in Mice Hypertension, April 1, 2004; 43(4): 854 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. McAnulty Jr., R. Moshenyat, Y. Kupfer, S. Tessler, U. P. Jorde, M. A. Pfeffer, J. J.V. McMurray, and R. M. Califf Valsartan, Captopril, or Both in Myocardial Infarction N. Engl. J. Med., February 26, 2004; 350(9): 943 - 945. [Full Text] [PDF]
|
|
|
|
|
|
J. O. Kokkonen, K. A. Lindstedt, and P. T. Kovanen Role For Chymase in Heart Failure: Angiotensin II-Dependent or -Independent Mechanisms? Circulation, May 27, 2003; 107(20): 2522 - 2524. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Leskinen, K. A. Lindstedt, Y. Wang, and P. T. Kovanen Mast Cell Chymase Induces Smooth Muscle Cell Apoptosis by a Mechanism Involving Fibronectin Degradation and Disruption of Focal Adhesions Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 238 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Tom, I. M. Garrelds, E. Scalbert, A. P.A. Stegmann, F. Boomsma, P. R. Saxena, and A.H. J. Danser ACE- Versus Chymase-Dependent Angiotensin II Generation in Human Coronary Arteries: A Matter of Efficiency? Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 251 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Jackman, M. G. Massad, M. Sekosan, F. Tan, V. Brovkovych, B. M. Marcic, and E. G. Erdos Angiotensin 1-9 and 1-7 Release in Human Heart: Role of Cathepsin A Hypertension, May 1, 2002; 39(5): 976 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. McDonald, N. Padmanabhan, M. C. Petrie, C. Hillier, J. M.C. Connell, and J. J.V. McMurray Vasoconstrictor Effect of the Angiotensin-Converting Enzyme-Resistant, Chymase-Specific Substrate [Pro11D-Ala12] Angiotensin I in Human Dorsal Hand Veins: In Vivo Demonstration of Non-ACE Production of Angiotensin II in Humans Circulation, October 9, 2001; 104(15): 1805 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Leskinen, Y. Wang, D. Leszczynski, K. A. Lindstedt, and P. T. Kovanen Mast Cell Chymase Induces Apoptosis of Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 516 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Barlucchi, A. Leri, D. E. Dostal, F. Fiordaliso, H. Tada, T. H. Hintze, J. Kajstura, B. Nadal-Ginard, and P. Anversa Canine Ventricular Myocytes Possess a Renin-Angiotensin System That Is Upregulated With Heart Failure Circ. Res., February 16, 2001; 88(3): 298 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A.A. Borland, A. H. Chester, S. J. Rooker, J. Wharton, N. Davie, M. Amrani, and M. H. Yacoub Expression and function of angiotensin converting enzyme, chymase, and angiotensin II in the human radial artery and internal thoracic artery Ann. Thorac. Surg., December 1, 2000; 70(6): 2054 - 2063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Arakawa and H. Urata Hypothesis Regarding the Pathophysiological Role of Alternative Pathways of Angiotensin II Formation in Atherosclerosis Hypertension, October 1, 2000; 36(4): 638 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Maruyama, E. Hatta, K. Yasuda, N. C. E. Smith, and R. Levi Angiotensin-Converting Enzyme-Independent Angiotensin Formation in a Human Model of Myocardial Ischemia: Modulation of Norepinephrine Release by Angiotensin Type 1 and Angiotensin Type 2 Receptors J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 248 - 254. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Kuoppala, K. A. Lindstedt, J. Saarinen, P. T. Kovanen, and J. O. Kokkonen Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1069 - H1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Schieffer, E. Schieffer, D. Hilfiker-Kleiner, A. Hilfiker, P. T. Kovanen, M. Kaartinen, J. Nussberger, W. Harringer, and H. Drexler Expression of Angiotensin II and Interleukin 6 in Human Coronary Atherosclerotic Plaques : Potential Implications for Inflammation and Plaque Instability Circulation, March 28, 2000; 101(12): 1372 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Saris, M. A. van Dijk, I. Kroon, M. A. D. H. Schalekamp, and A. H. J. Danser Functional Importance of Angiotensin-Converting Enzyme-Dependent In Situ Angiotensin II Generation in the Human Forearm Hypertension, March 1, 2000; 35(3): 764 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.H.J. Danser, J. J Saris, M. P Schuijt, and J. P van Kats Is there a local renin--angiotensin system in the heart? Cardiovasc Res, November 1, 1999; 44(2): 252 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. MaassenVanDenBrink, R. de Vries, P. R. Saxena, M. A.D.H. Schalekamp, and A.H.J. Danser Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase Cardiovasc Res, November 1, 1999; 44(2): 407 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C Wollert and H. Drexler The renin-angiotensin system and experimental heart failure Cardiovasc Res, September 1, 1999; 43(4): 838 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Takai, D. Jin, M. Sakaguchi, and M. Miyazaki Chymase-Dependent Angiotensin II Formation in Human Vascular Tissue Circulation, August 10, 1999; 100(6): 654 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Wei, Q. C. Meng, R. Palmer, G. R. Hageman, J. Durand, W. E. Bradley, D. M. Farrell, G. H. Hankes, S. Oparil, and L. J. Dell'Italia Evidence for Angiotensin-Converting Enzyme– and Chymase-Mediated Angiotensin II Formation in the Interstitial Fluid Space of the Dog Heart In Vivo Circulation, May 18, 1999; 99(19): 2583 - 2589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. Kokkonen, A. Kuoppala, J. Saarinen, K. A. Lindstedt, and P. T. Kovanen Kallidin- and Bradykinin-Degrading Pathways in Human Heart : Degradation of Kallidin by Aminopeptidase M–Like Activity and Bradykinin by Neutral Endopeptidase Circulation, April 20, 1999; 99(15): 1984 - 1990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nicoletti and J.-B. Michel Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors Cardiovasc Res, March 1, 1999; 41(3): 532 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang and P. T. Kovanen Heparin Proteoglycans Released From Rat Serosal Mast Cells Inhibit Proliferation of Rat Aortic Smooth Muscle Cells in Culture Circ. Res., January 22, 1999; 84(1): 74 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. van Kats, A. H. J. Danser, J. R. van Meegen, L. M. A. Sassen, P. D. Verdouw, and M. A. D. H. Schalekamp Angiotensin Production by the Heart : A Quantitative Study in Pigs With the Use of Radiolabeled Angiotensin Infusions Circulation, July 7, 1998; 98(1): 73 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Brooks, O. H. L. Bing, C. H. Conrad, L. O'Neill, M. T. Crow, E. G. Lakatta, D. E. Dostal, K. M. Baker, and M. O. Boluyt Captopril Modifies Gene Expression in Hypertrophied and Failing Hearts of Aged Spontaneously Hypertensive Rats Hypertension, December 1, 1997; 30(6): 1362 - 1368. [Abstract] [Full Text]
|
|